AzTrials
AzTrials

Wear of Articular Bearing Surface of Internal Prosthetic JointSHARPNCT04620395

Percutaneous Punch Biopsy for Diagnosis of Septic and Aseptic Prosthetic Joint Failure

A study testing Punch biopsy in people with Wear of Articular Bearing Surface of Internal Prosthetic Joint and Infection Prosthetic, run by Vivantes Netzwerk für Gesundheit GmbH at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the superiority study is to establish a reproducible, minimally invasive, cost-effective way of sample collection for microbiological and pathomorphological processing in a clinical setting with avoidance of anesthesia, multiple punctures, as well as potential deep contamination during irrigation. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Punch biopsy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
132 participants
Where
1 siteGermany
Study dates
20 Aug 2020to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Preceding implantation of a shoulder, hip or knee endoprosthesis
  • Acute or chronic pain in the joint
  • Periprosthetic fracture
  • Instability of the endoprosthesis
  • Indications of wear / insufficiency of the enclosed plastic spacers
  • Indications of metal abrasion
  • Primary misalignment of the implant

Who cannot join

  • Confirmed periprosthetic infection
  • Proven allergy to fast-acting local anesthetics

Trial locations and contacts

1 site in 1 country.

Rafal J Borucki, MD contact

+4915129211687

rafal.borucki@vivantes.de

Germany1 site, 1 recruiting
  • Vivantes Humboldt-Krankenhaus

    Berlin, 13509

    Karsten Labs, PD Dr. med., +4930130121655, karsten.labs@vivantes.de

    Rafal J Borucki, MD, +4915129211687, rafal.borucki@vivantes.de

    Recruiting

Other trials in Germany

About this study

Official title: Clinical Investigation of Septic and Aseptic Prosthetic Joint Failure - Percutaneous Punch Biopsy as a Novel Way of Diagnosis Confirmation

The aim of the superiority study is to establish a reproducible, minimally invasive, cost-effective way of sample collection for microbiological and pathomorphological processing in a clinical setting with avoidance of anesthesia, multiple punctures, as well as potential deep contamination during irrigation.

Read the detailed description

The main aim of the study is to demonstrate the superiority of a punch biopsy over a joint tap to rule out or prove septic prosthesis failure and thus establish a new diagnostic method. The subsequently calculated sensitivities of the previous and the procedure are used as the main indicator. In addition, we would like to prove that the total cost of diagnosing a septic / aseptic prosthesis failure using the proposed method has socio-economic advantages over the previous algorithm.

One of the secondary objectives is the evaluation of the use of a punch biopsy for simultaneous a priori pathomorphological examination of periprosthetic soft tissue samples for the determination of wear particles. Furthermore, the study is intended to demonstrate a shortening of the time span between the first suspected diagnosis of septic prosthesis failure and its reliable exclusion / detection.

Being tested
Punch biopsy
Keywords
prosthetic joint, infection, wear particles, prosthetic failure, antibiotics, biopsy, joint tap
Medical subject headings
Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Punch biopsyDiagnostic test

    A standardized biopsy kit is used for a synovial fluid tap and subsequent acquisition of up to 7 Punch biopsies through an introducer (part of the kit)

Study groups in NCT04620395
Study groupRoleWhat they receive
Joint tapNo interventionJoint tap and aspiration of synovial fluid
Punch biopsyExperimentalPunch biopsy of a prosthetic joint and extraction of 5-7 biopsies from the synovial membrane
Receives: Diagnostic Test: Punch biopsy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improved diagnostic accuracy

    Comparison of the specificity and sensibility of microbiological results for punch biopsies, the synovial fluid tap, pre-interventional blood Analysis, arthroscopic biopsies for confirmation/exclusion of a bacterial or fungal periprosthetic infection

    Measured: up to 3 months

Secondary outcomes (5)
  1. Rate of chronic periprosthetic low-grade-infections

    The incidence of hidden chronic periprosthetic infections

    Measured: up to 3 Months

  2. Correlation of microbiological results from percutaneous Punch biopsy with intraoperative findings at Revision

    Correlation of pre-revision microbiological findings and the samples taken during the endoprosthesis replacement operation, in particular the sonicate of the prosthesis and the periprosthetic membrane (gold standard for infection diagnostics)

    Measured: up to 6 Months

  3. Total Cost of Infection Diagnostics for various used methods

    Comparison of the respective Overall Costs for diagnostics of acute and chronic periprosthetic infections using a joint-tap, the novel punch biopsy method and arthroscopic biopsy

    Measured: 1 Month

  4. Rate of prosthetic failure due to wear particles

    Incidence of presence of wear particles in pathomorphological examinations of the punch biopsies and the samples taken during the replacement operation

    Measured: up to 1 month

  5. Correlation of Synovialitis score and microbiological findings

    Correlation of Synovialitis score in pathomorphological examinations and microbiological verification of an acute or chronic periprosthetic infection

    Measured: up to 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2020
  2. Study start20 Aug 2020
  3. Primary completion31 Jan 2022 (estimated)
  4. Study completion30 Jun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
132 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04620395
Sponsor's protocol ID
STUD.20-062
Other IDs
DRKS00022931, U1111-1257-2609
Acronym
SHARP
Status last verified
Nov 2020
First submitted
25 Aug 2020
Last updated
9 Nov 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Punch biopsy in people with Wear of Articular Bearing Surface of Internal Prosthetic Joint and Infection Prosthetic, run by Vivantes Netzwerk für Gesundheit GmbH at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rafal J Borucki, MD (+4915129211687, rafal.borucki@vivantes.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improved diagnostic accuracy (time frame: up to 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in